Inventor
KLEIN LAWRENCE
US37 patents
⚠️ This page may combine multiple inventors who share the name “KLEIN LAWRENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CRISPR THERAPEUTICS AG
19 patentsUS10736919B2Aug 11, 2020
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG13 citations94
US11071755B1Jul 27, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG7 citations92
US10881689B2Jan 5, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG7 citations92
US10857184B2Dec 8, 2020
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG9 citations92
US10729725B2Aug 4, 2020
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG7 citations92
US11166985B2Nov 9, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG10 citations86
US11298378B2Apr 12, 2022
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG2 citations84
US11207351B2Dec 28, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG3 citations84
US11202802B2Dec 21, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG2 citations84
US11191783B2Dec 7, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG6 citations84
US11135247B2Oct 5, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG6 citations84
US11013767B2May 25, 2021
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG5 citations84
US11559588B2Jan 24, 2023
Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders
CRISPR THERAPEUTICS AG12 citations83
US11622977B2Apr 11, 2023
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG1 citations73
US11471491B1Oct 18, 2022
Materials and methods for engineering cells and uses thereof in immuno-oncology
CRISPR THERAPEUTICS AG1 citations73
US11174469B2Nov 16, 2021
Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders
CRISPR THERAPEUTICS AG1 citations60
US11920148B2Mar 5, 2024
Compositions and methods for gene editing
CRISPR THERAPEUTICS AG0 citations57
US11564997B2Jan 31, 2023
Materials and methods for treatment of friedreich ataxia and other related disorders
CRISPR THERAPEUTICS AG0 citations50
US11407997B2Aug 9, 2022
Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders
CRISPR THERAPEUTICS AG0 citations50
ECONOMIC ALCHEMY INC
7 patentsUS11587172B1Feb 21, 2023
Methods and systems to quantify and index sentiment risk in financial markets and risk management contracts thereon
ECONOMIC ALCHEMY INC9 citations84
US11599892B1Mar 7, 2023
Methods and systems to extract signals from large and imperfect datasets
ECONOMIC ALCHEMY INC2 citations71
US11593886B1Feb 28, 2023
Methods and systems to quantify and index correlation risk in financial markets and risk management contracts thereon
ECONOMIC ALCHEMY INC1 citations71
US11551305B1Jan 10, 2023
Methods and systems to quantify and index liquidity risk in financial markets and risk management contracts thereon
ECONOMIC ALCHEMY INC2 citations71
US12373890B1Jul 29, 2025
Methods and systems to quantify and index correlation risk in financial markets and risk management contracts thereon
ECONOMIC ALCHEMY INC0 citations61
US11941645B1Mar 26, 2024
Methods and systems to extract signals from large and imperfect datasets
ECONOMIC ALCHEMY INC0 citations61
US11854083B1Dec 26, 2023
Methods and systems to quantify and index liquidity risk in financial markets and risk management contracts thereon
ECONOMIC ALCHEMY INC0 citations61
VERTEX PHARMA
4 patentsUS11459587B2Oct 4, 2022
Materials and methods for treatment of pain related disorders
VERTEX PHARMA3 citations71
US12442020B2Oct 14, 2025
Materials and methods for treatment of pain related disorders
VERTEX PHARMA0 citations60
US11427838B2Aug 30, 2022
Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders
VERTEX PHARMA1 citations60
US11801313B2Oct 31, 2023
Materials and methods for treatment of pain related disorders
VERTEX PHARMA0 citations50
OUTRIDER TECH INC
3 patentsUS12405384B2Sep 2, 2025
Systems and methods for determining an articulated trailer angle
OUTRIDER TECH INC0 citations54
US11927676B2Mar 12, 2024
Systems and methods for determining an articulated trailer angle
OUTRIDER TECH INC1 citations54
US11787486B2Oct 17, 2023
Motor stall and trailer lift
OUTRIDER TECH INC0 citations52